PD-1/PD-L1 Inhibitor 1 |
|||
B1213-25 | Biovision | each | EUR 679.2 |
Human IgG antibody Laboratories manufactures the promega pd-1/pd-l1 cell reagents distributed by Genprice. The Promega Pd-1/Pd-L1 Cell reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Promega. Other Promega products are available in stock. Specificity: Promega Category: Pd-1/Pd-L1 Group: Cell
PD-L1 Antibody |
||
ProSci | 0.1 mg | EUR 523.7 |
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
PD-L1 Antibody |
||
SAB | 0.1m | EUR 224.4 |
PD-L1 Antibody |
||
SAB | 1ml | EUR 807.6 |
PD-L1 Antibody |
||
NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Programmed cell death 1 ligand 1; CD274 |
PD-L1 Antibody |
||
NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Programmed death-ligand 1, also known as CD274 or B7-H1 is a protein that in humans is encoded by the CD274 gene. It is a 33-70kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Upregulation on tumor MDCs downregulates T-cell immunity and PD-L1 blockade may represent an approach for cancer immunotherapy. It can provide positive costimulatory signals for innate and adaptive immunity and for protection against intracellular bacterial infection. It has been found that PD1/PDL1 pathway may be a good target for restoring antitumor immunity in ovarian cancer. |
PD-1:PD-L1 Homogeneous Assay Kit |
||
BPS Bioscience | 384 rxns. | EUR 1070 |
Description: The PD-1:PD-L1 Homogeneous Assay Kit is designed to measure the_x000D_inhibition of PD-1 binding to PD-L1. With this kit, only three simple steps on a microtiter_x000D_plate are required. First, a sample containing PD-1 and an inhibitor of choice is incubated with_x000D_the biotinylated PD-L1 for 60 minutes. Next, acceptor beads are added, then donor beads,_x000D_followed by reading the Alpha-counts. |
PD-1:PD-L1 TR-FRET Assay |
||
BPS Bioscience | 96 rxns. | EUR 745 |
Description: The PD-1:PD-L1 TR-FRET Assay is designed to measure the inhibition of PD-1 binding to PD-L1 in a homogeneous 96 reaction format. This FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; a sample containing europium-labeled (Eu) PD-1, dye-labeled acceptor, biotin-labeled PD-L1, and an inhibitor is incubated for two hours. Then, the fluorescence intensity is measured using a fluorescence reader. |
PD-L1 Peptide |
|||
46-156P | ProSci | 0.1 mg | EUR 405.6 |
Description: CD274 / PD-L1 Peptide |
Anti-PD-L1 |
|||
DB-241-0.1 | DB Biotech | 100 μl | EUR 469.2 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-PD-L1 |
|||
DB-241-0.2 | DB Biotech | 200 μl | EUR 675.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-PD-L1 |
|||
DB-241-0.5 | DB Biotech | 500 μl | EUR 889.2 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-PD-L1 |
|||
DB-241-1 | DB Biotech | 1 ml | EUR 1450.8 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
Anti-PD-L1 |
|||
DB-241-RTU-15 | DB Biotech | 15 ml | EUR 813.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-PD-L1 |
|||
DB-241-RTU-7 | DB Biotech | 7 ml | EUR 519.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-PD-L1 |
|||
DB241-RTU-15 | DB Biotech | 15 ml | EUR 813.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
Anti-PD-L1 |
|||
DB241-RTU-7 | DB Biotech | 7 ml | EUR 519.6 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
PD-L1 Antibody |
|||
P1013-01m | SAB | 0.1m | EUR 224.4 |
PD-L1 Antibody |
|||
P1013-1ml | SAB | 1ml | EUR 807.6 |
PD-L1, CD274 |
|||
E6TA00108 | EnoGene | 0.1mg | EUR 411.6 |
PD-L1 Antibody |
|||
R31573 | NSJ Bioreagents | 100 ug | EUR 356.15 |
Description: Programmed death-ligand 1, also known as CD274 or B7-H1 is a protein that in humans is encoded by the CD274 gene. It is a 33-70kDa type 1 transmembrane protein that has been speculated to play a major role in suppressing the immune system during particular events such as pregnancy, tissue allografts, autoimmune disease and other disease states such as hepatitis. Upregulation on tumor MDCs downregulates T-cell immunity and PD-L1 blockade may represent an approach for cancer immunotherapy. It can provide positive costimulatory signals for innate and adaptive immunity and for protection against intracellular bacterial infection. It has been found that PD1/PDL1 pathway may be a good target for restoring antitumor immunity in ovarian cancer. |
PD-L1 Antibody |
|||
R33263-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
Description: Additional name(s) for this target protein: Programmed cell death 1 ligand 1; CD274 |
PD-1[Biotinylated]:PD-L1 Homogeneous Assay Kit |
|||
72028 | BPS Bioscience | 384 rxns. | EUR 1070 |
Description: The PD-1[Biotinylated]:PD-L1 Homogeneous Assay Kit is designed to measure_x000D_the inhibition of PD-1 binding to PD-L1. The PD-1[Biotinylated]:PD-L1 Homogeneous Assay Kit_x000D_comes in a convenient AlphaLISA® format with purified biotinylated PD-1, FLAG-tagged PD-L1,_x000D_and assay buffer to perform a total of 384 reactions. With this kit, only three simple steps on a_x000D_microtiter plate are required. First, a sample containing biotinylated PD-1 and an inhibitor of_x000D_choice is incubated with the FLAG-tagged PD-L1 for 60 minutes. Next, acceptor beads are_x000D_added, then donor beads, followed by reading the Alpha-counts. |
Programmed Cell Death 1 Ligand 1 (PD-L1) Antibody |
|||
abx236280-100ug | Abbexa | 100 ug | EUR 577.2 |
Programmed Cell Death 1 Ligand 1 (PD-L1) Antibody |
|||
abx236281-100ug | Abbexa | 100 ug | EUR 610.8 |